News

The Pulmonary Fibrosis Foundation medical team is actively monitoring the evolving outbreak of the COVID-19 coronavirus to evaluate the potential health implications for the pulmonary fibrosis (PF) community in the USA. Read our Guidance Statement here.

The Pulmonary Fibrosis Foundation medical team is actively monitoring the evolving outbreak of the COVID-19 coronavirus to evaluate the potential health implications for the pulmonary fibrosis (PF) community in the USA.

The Pulmonary Fibrosis Foundation and Celgene Corporation, a wholly owned subsidiary of Bristol-Myers Squibb Company, have created a consortium called PROLIFIC (Prognostic Lung Fibrosis Consortium) to develop well-qualified assays to detect important peripheral blood protein biomarkers in patients with pulmonary fibrosis. The assays will be used to uncover early indicators of a drug’s activity.

Pulmonary Fibrosis Foundation National Awareness Survey reveals little understanding of disease in advance of Rare Disease Week.

Multi-Tony Award-Winner, Bernadette Peters (Hello, Dolly!, Follies, A Little Night Music), along with New York’s theatrical community, will raise funds and awareness for pulmonary fibrosis (PF), a debilitating lung disease, in the 10th annual Broadway Belts for PFF!

The Pulmonary Fibrosis Foundation (PFF) today announced that 59 pulmonary fibrosis (PF) support groups nationwide received grants from the 2019 Leanne Storch Support Group Fund. The Fund is sponsored by Boehringer Ingelheim and Genentech, a Roche company. Named for the PFF’s former executive director who was diagnosed with PF in 2003, the Leanne Storch Support Group Fund honors her passion for supporting those affected by the disease.